Literature DB >> 12078848

Spiradenocarcinoma of the scalp.

Brian W Russ1, Jeffrey Meffert, Richard Bernert.   

Abstract

Spiradenocarcinoma is an exceedingly rare malignant neoplasm with ductal differentiation. Many consider it to be an eccrine neoplasm, and others favor apocrine differentiation. In nearly all cases, spiradenocarcinoma is associated with a benign spiradenoma, with most lesions appearing on the trunk and extremities. We describe a patient who presented with a long-standing and previously asymptomatic scalp nodule that became tender and enlarged. After diagnosis of spiradenocarcinoma, the patient was referred for lymphoscintigraphy, sentinal lymph node biopsy, and Mohs micrographic surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12078848

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  A malignant eccrine spiradenoma of the scalp.

Authors:  Whitney Chow; Mat Griffiths
Journal:  BMJ Case Rep       Date:  2014-05-19

2.  Direct intracranial extension of malignant eccrine spiradenoma of the face.

Authors:  Srinivas B Pedamallu; Justin Murphy; Douglas Boyd; Dominic Martin-Hirsch; Khaled Al-Zwae
Journal:  J Clin Med Res       Date:  2009-08-20

3.  [Spiradenocarcinoma of the forehead : A rare skin tumor in the head and neck region].

Authors:  D Schwarz; H Göbel; A-O Gostian; M F Meyer; A Anagiotos
Journal:  HNO       Date:  2016-05       Impact factor: 1.284

4.  Fine needle aspiration cytology of eccrine spiradenoma of back: report of a rare case.

Authors:  Anuradha Sinha; Subrata Pal; Jyoti Prakash Phukan
Journal:  J Lab Physicians       Date:  2014-07

Review 5.  Direct intracranial invasion of eccrine spiradenocarcinoma of the scalp: a case report and literature review.

Authors:  Yuji Kibe; Kuniaki Tanahashi; Kazuhiro Ohtakara; Yuka Okumura; Fumiharu Ohka; Kazuhito Takeuchi; Yuichi Nagata; Kazuya Motomura; Sho Akahori; Akihiro Mizuno; Hiroo Sasaki; Hiroyuki Shimizu; Junya Yamaguchi; Tomohide Nishikawa; Kenji Yokota; Ryuta Saito
Journal:  BMC Neurol       Date:  2022-06-18       Impact factor: 2.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.